Hold Sun Pharmaceutical Industries target of Rs 510: Sharekhan
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 510 in its research report dated May 27, 2020.
Sharekhan’s research report on Sun Pharmaceutical Industries
Sun Pharma reported healthy results for Q4FY2020; however numbers missed estimates. Sun Pharmaceutical industries (Sun Pharma) is witnessing sustained competitive pressures in the US generic business, which are unlikely to abate in the near to medium term. Also the momentum for the specialty business is likely to slow down in the near term due to covid impact. Domestic formulations, could also witness a slowdown in the current quarter on the back of Covid related issues which could impact the demand due to lower prescriptions written and advance stocking of chronic medicines.
Given persistent uncertainties in US business and India business in the near-medium term, we hold back from taking a constructive view and retain a Hold recommendation on the stock with a revised PT of Rs 510.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Get best insights into Options Trading. Webinar by Mr. Vishal B Malkan is Live. Watch Now!
First Published on May 28, 2020 04:35 pm